Remove 2028 Remove Dosage Remove Pharmaceutical Companies
article thumbnail

N-FIS was developed to address a critical challenge in healthcare—needle phobia

Express Pharma

Key parameters, such as pressure and orifice size, are carefully calibrated to achieve accurate drug delivery at the desired depth and dosage, making it a safe and efficient alternative to traditional needle injections. billion in 2028, growing at a compound annual growth rate (CAGR) of 14.16

article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

Sustainability in pharmaceutical manufacturing AstraZeneca – biomethane supply AstraZeneca will establish the first industrial-scale supply of biomethane” In mid-September, a 15-year partnership between AstraZeneca and Future Biogas was agreed. Subject to planning permission, the site is expected to be opened by 2028.